Anouchka Modesto MD PhD

radiation oncologist @iuct_oncopole Toulouse France in charge of head and neck and GI tumor

[Anouchka Modesto MD PhD @AnouchkaModesto]

@YG_TAO @PBlanchardMD @DrMLChua @GorphePhilippe Wonderful results 📣opening soon 🤞🤞new opportunities for our patients!!

[Yungan TAO @YG_TAO]

Excited to share the final publication in The Lancet of our phase 3 GORTEC 2018-01 (NIVOPOST-OP) trial results. We hope these results will support changes in clinical practice and future guideline updates. @PBlanchardMD @DrMLChua @GorphePhilippe https://t.co/TpPrhMkbOs

[Nirmal Raut @oncologician]

Medical oncologist Vs Radiation oncologist

[Pierre Blanchard, MD @PBlanchardMD]

Words of wisdom from @_MichaelBaumann on the future of radiation oncology, recipient of the 2025 @profOvergaard award.
Well deserved!
#ESTRO25

[Pierre Blanchard, MD @PBlanchardMD]

Hot of the press @IJROBP: Role of SABR in oligometastatic head and neck cancer: a GORTEC randomized trial

Full text here: https://t.co/MuEI1uURxQ

[Yungan TAO @YG_TAO]

Honored to contribute as co-PI to our Phase 3 trial NIVOPOSTOP GORTEC 2018-01 evaluating nivolumab in addition to post-operative concurrent CRT for resected HR LAHNSCC pts, which met its primary endpoint of DFS across all comers. @PBlanchardMD @GustaveRoussy

[Jacques Attali @jattali]

N’écoutez pas ceux qui dénigrent vos projets. Ils ne font que dire leur mal-être.

[IUCT Oncopole @IUCTOncopole]

#ASCO2024

Les équipes de l’IUCT-Oncopole sont au rendez-vous de l’édition 2024 du congrès de l’American Society of Clinical Oncology (ASCO).

Vous souhaitez en savoir plus sur les temps forts de l'édition 2024 ? ⤵️

[Yungan TAO @YG_TAO]

Honored to contribute to this phase 3 trial KEYNOTE-412: Pembrolizumab + CRT probably better than CRT in selected patients with LA-SCCHN, still waiting for results from more follow-up later. @PBlanchardMD @BenjaminBesseMD @DrMLChua
https://t.co/aNiw9N5NNZ

[Anouchka Modesto MD PhD @AnouchkaModesto]

Nice talk from ⁦my colleague and friend @PBlanchardMD⁩ on radio induced dysphagia at ICHNO 2024. #ichno2024 #headandneckcancer #Barcelona

[Pierre Blanchard, MD @PBlanchardMD]

Role of adjuvant nivolumab after salvage surgery for relapse after chemo radiation for head and neck cancer presented by Dr Even from @GustaveRoussy.

Feasible. Acceptable toxicity. Efficacy depends on TPS/CPS.

#ESMO23

[The Nobel Prize @NobelPrize]

A round of applause!

Students and colleagues at @lunduniversity came together to recognise newly named physics laureate Anne L’Huillier.

Drop a 👏 in the comments to congratulate our new Nobel Prize laureate.

Video credit: Nina Ransmyr, Lund University

[Anouchka Modesto MD PhD @AnouchkaModesto]

@francebleu @Anne_Orenstein Un grand merci 🙏pour votre accueil, la qualité de votre émission et l intérêt que vous portez aux cancers ORL et à la campagne du comité ORL de l @IUCTOncopole!

[ICI @ici_officiel]

Cancers ORL : "Le tabac joue un rôle de cofacteur avec l'infection au papillomavirus"

📌 Cancérologue radiothérapeute, @AnouchkaModesto explique que "ces maladies touchent souvent des personnes âgées entre 50 et 60 ans" #BonjourDocteur @Anne_Orenstein

[soria @jsoriamd]

Oncology is a demanding profession, asking a great amount of those practicing in the field. Oncology clinicians can set boundaries while still meeting ethical practice standards. Setting boundaries may ultimately allow clinicians to be more present & engaged while working, have more satisfaction with their work, & maintain personal well-being. Some great suggestions in this table & article https://t.co/oVqeXt1Qgz

[Le Figaro @Le_Figaro]

Sous couvert d'anonymat, @JacobEtienne, journaliste du «Figaro» a participé à un stage organisé par des naturopathes, dont Irène Grosjean. Un système savamment rodé, sur fond de dérives sectaires. Il raconte les coulisses de son enquête.

[Gustave Roussy @GustaveRoussy]

👏 Félicitations au Pr Eric Deutsch @Edradonc, chef du département de Radiothérapie à @GustaveRoussy, qui a reçu lors de l’#ESTRO23 le Prix Regaud, remis par @Mat_Guc, président élu @ESTRO

[Radiotherapy & Oncology @RO_GreenJournal]

New article alert (Vol. 184)

High-dose versus standard-dose radiotherapy in concurrent chemoradiotherapy for inoperable esophageal cancer: A systematic review and meta-analysis
Yuanhu Yao et al.

https://t.co/mBReGbVTpB

[Emma B. Holliday MD @DrEmmaHolliday]

There has been a lot of 🔥discussion lately of short course radiation (SCRT) for locally advanced rectal cancer (LARC).
I❤️SCRT bc it is convenient for working patients or those who travel for 🏥care. However, the RAPIDO update gives me pause. Let’s look at the history of SCRT:

[Dr. Nina Niu Sanford @NiuSanford]

In this week's @JAMA_current, my husband @EthanLSanford writes about the deaths of our daughter Ceci and his patient Terry.

About how grief has informed his practicing of medicine and living a fuller life.

Please read about our girl and share.

https://t.co/0Ku2IDEl3g